Who founded Global Vascular株式会社?

Global Vascular株式会社 was founded by Kenta Bito, Shunto Maegawa.

Who are Global Vascular株式会社's investors?

Global Vascular株式会社's investors include Fast Track Initiative, Tokyo University of Science Innovation Capital, Mitsubishi UFJ Capital, Mitsui Sumitomo Insurance Capital, Sumitomo Mitsui Trust Bank.

Where is Global Vascular株式会社 headquartered?

Global Vascular株式会社 is headquartered in Tokyo, JP.

Global Vascular株式会社

Tokyo, JP · 5 known investors

Find your way into Global Vascular株式会社

390 people in our graph share verified history with the Global Vascular株式会社 team — schools, employers, funds. One of them is your warm intro.

Yoyo Yangunlockedknows Emi Matsuoka · together at Waseda University (overlapped)

×4knows the team · via Keio University

×3knows the team · via Waseda University

knows the team · via University of Redlands

×3knows the team · via Fox School of Business at Temple University

Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.

Deep Tech Healthtech Medical Devices New Materials

Founders & leadership

Kenta BitoinFounder & CEO

Shunto MaegawainFounder & CTO

Emi Matsuoka inCOOEmi Matsuoka has over 20 years of medical device industry experience, including roles as an R&D engineer at Terumo Corporation on stent delivery systems, liaison engineer at Abbott Vascular Japan in the US, and senior product marketing manager for interventional devices. She previously managed medical device development projects at Keio University's Clinical and Translational Research Center and holds an MEng in Polymer Engineering, an executive MBA, and a PhD in Biomedical Sciences.

Hayato Maekawa

Board

Terumitsu HasebeBoard director

Investors · 5

Fast Track Initiative✓ verifiedTokyo · $1.2M – $184M

Tokyo University of Science Innovation Capital✓ verifiedTokyo

Mitsubishi UFJ Capital✓ verifiedTokyo · $952K – $269M

Mitsui Sumitomo Insurance Capital✓ verifiedTokyo · $1.1M – $198M

Sumitomo Mitsui Trust Bank✓ verified

Competitors · 1

by search overlap

Medscape12 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Global Vascular株式会社 for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Global Vascular株式会社 do?: Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.
Who founded Global Vascular株式会社?: Global Vascular株式会社 was founded by Kenta Bito, Shunto Maegawa.
Who are Global Vascular株式会社's investors?: Global Vascular株式会社's investors include Fast Track Initiative, Tokyo University of Science Innovation Capital, Mitsubishi UFJ Capital, Mitsui Sumitomo Insurance Capital, Sumitomo Mitsui Trust Bank.
Where is Global Vascular株式会社 headquartered?: Global Vascular株式会社 is headquartered in Tokyo, JP.